B+
Bull case
20%
Probability
Target price
$170.00
+300.6% vs current
INSP
Inspire MedicalDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-11
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$120.00
+182.8% vs current
B-
Bear case
20%
Probability
Target price
$75.00
+76.7% vs current
AI sentiment snapshot
Latest data as of 2026-01-16
Recent news sentiment (30D)
-29.3
Negative
Company
-
Unavailable
Macro
-29.3
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Market sentiment is mixed: analyst targets are widely dispersed, implying upside in some models but significant disagreement on adoption and reimbursement. Near-term prints and payer signals will likely drive re-rating.
RankAlpha Sentiment AI - 2026-01-16
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-16catalystNext quarterly results / guidanceHigh impact
Upcoming quarterly results could drive a near-term re-rating if Inspire reports procedure growth and margin beats versus expectations; analyst consensus and targets show material upside range [#SERP-1].
2027-01-16catalystExpanded reimbursement and clinical adoptionHigh impact
Broader payer coverage and increased adoption of hypoglossal nerve stimulation over the next year could materially lift revenue and valuation versus current anchor [#SERP-6].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-16 • Updated nightlySource: Internal modelMethodology